Publicaciones en colaboración con investigadores/as de University Hospital Heidelberg (8)

2022

  1. Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 28, Núm. 21, pp. 4771-4781

  2. Differentially methylated regions within lung cancer risk loci are enriched in deregulated enhancers

    Epigenetics, Vol. 17, Núm. 2, pp. 117-132

  3. Identification of NHLRC1 as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS)

    International Journal of Molecular Sciences, Vol. 23, Núm. 18

  4. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. SARS-CoV-2 and Stroke Characteristics: A Report From the Multinational COVID-19 Stroke Study Group

    Stroke, Vol. 52, Núm. 5, pp. E117-E130

2017

  1. The not-so-good prognosis of streptococcal periprosthetic joint infection managed by implant retention: The results of a large multicenter study

    Clinical Infectious Diseases, Vol. 64, Núm. 12, pp. 1742-1752

2013

  1. Brush border myosin Ia inactivation in gastric but not endometrial tumors

    International Journal of Cancer, Vol. 132, Núm. 8, pp. 1790-1799

2012

  1. Brush border Myosin Ia has tumor suppressor activity in the intestine

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Núm. 5, pp. 1530-1535